AstraZeneca PLC (ZEGA) — Cash Flow-to-Debt Ratio
AstraZeneca PLC (ZEGA) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of €5.13 Billion could theoretically repay 0% of its total liabilities (€68.48 Billion) in one year. See AstraZeneca PLC (ZEGA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AstraZeneca PLC Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for AstraZeneca PLC across 11 annual periods. Also explore ZEGA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for AstraZeneca PLC (2014–2024)
Year-by-year debt coverage analysis for AstraZeneca PLC. For market capitalisation and broader financial context, see market cap of AstraZeneca PLC.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | €11.86 Billion | €63.16 Billion | ▲ +12.3% |
| 2023 | 0.17x | €10.36 Billion | €61.95 Billion | ▲ +1.3% |
| 2022 | 0.17x | €9.81 Billion | €59.42 Billion | ▲ +82.9% |
| 2021 | 0.09x | €5.96 Billion | €66.08 Billion | ▼ -3.9% |
| 2020 | 0.09x | €4.80 Billion | €51.09 Billion | ▲ +48.0% |
| 2019 | 0.06x | €2.97 Billion | €46.78 Billion | ▲ +13.0% |
| 2018 | 0.06x | €2.62 Billion | €46.61 Billion | ▼ -26.7% |
| 2017 | 0.08x | €3.58 Billion | €46.71 Billion | ▼ -15.3% |
| 2016 | 0.09x | €4.14 Billion | €45.86 Billion | ▲ +13.0% |
| 2015 | 0.08x | €3.32 Billion | €41.55 Billion | ▼ -55.8% |
| 2014 | 0.18x | €7.06 Billion | €38.95 Billion | — |